140 related articles for article (PubMed ID: 33548921)
1. Long-Term Outcomes of Intra-Arterial Chemotherapy for Progressive or Unresectable Pilocytic Astrocytomas: Case Studies.
Uluc K; Siler DA; Lopez R; Varallyay C; Netto JP; Firkins J; Lacy C; Huddleston A; Ambady P; Neuwelt EA
Neurosurgery; 2021 Mar; 88(4):E336-E342. PubMed ID: 33548921
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for pilocytic astrocytomas.
Brown MT; Friedman HS; Oakes WJ; Boyko OB; Hockenberger B; Schold SC
Cancer; 1993 May; 71(10):3165-72. PubMed ID: 8490847
[TBL] [Abstract][Full Text] [Related]
3. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
4. [Selected arterial infusion chemotherapy combined with target drugs for non-small cell lung cancer with multiple brain metastase].
Li J; Guo Z
Zhongguo Fei Ai Za Zhi; 2012 May; 15(5):305-8. PubMed ID: 22613338
[TBL] [Abstract][Full Text] [Related]
5. Trametinib for progressive pediatric low-grade gliomas.
Kondyli M; Larouche V; Saint-Martin C; Ellezam B; Pouliot L; Sinnett D; Legault G; Crevier L; Weil A; Farmer JP; Jabado N; Perreault S
J Neurooncol; 2018 Nov; 140(2):435-444. PubMed ID: 30097824
[TBL] [Abstract][Full Text] [Related]
6. [Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases].
Zhang JP; Shi HL; Sai K; Yue WY; Mu YG; Zhang XH; Chen ZP
Ai Zheng; 2006 Dec; 25(12):1533-7. PubMed ID: 17166381
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children.
Hsu TR; Wong TT; Chang FC; Ho DM; Tang RB; Thien PF; Chang KP
Childs Nerv Syst; 2008 Dec; 24(12):1457-61. PubMed ID: 18769928
[TBL] [Abstract][Full Text] [Related]
8. Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors.
Madajewicz S; Chowhan N; Iliya A; Roque C; Beaton R; Davis R; Fertman S; Meek A; Alvarez O; Pampati M
Cancer; 1991 Jun; 67(11):2844-9. PubMed ID: 1851050
[TBL] [Abstract][Full Text] [Related]
9. Commentary: Long-Term Outcomes of Intra-Arterial Chemotherapy for Progressive or Unresectable Pilocytic Astrocytomas: Case Studies.
Lukas RV
Neurosurgery; 2021 Mar; 88(4):E343-E344. PubMed ID: 33548920
[No Abstract] [Full Text] [Related]
10. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
11. Leksell Gamma Knife treatment for pilocytic astrocytomas: long-term results.
Simonova G; Kozubikova P; Liscak R; Novotny J
J Neurosurg Pediatr; 2016 Jul; 18(1):58-64. PubMed ID: 26991883
[TBL] [Abstract][Full Text] [Related]
12. Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma.
Mercurio S; Padovani L; Colin C; Carré M; Tchoghandjian A; Scavarda D; Lambert S; Baeza-Kallee N; Fernandez C; Chappé C; André N; Figarella-Branger D
Acta Neuropathol Commun; 2013 May; 1():17. PubMed ID: 24252689
[TBL] [Abstract][Full Text] [Related]
13. An elderly patient presenting with a primary spinal multifocal intradural extramedullary pilocytic astrocytoma: a case report and review of the literature.
McBride D; Aljuboori Z; Hattab EM; Downs R; Woo S; Williams B; Neimat J; Burton E
BMC Cancer; 2018 Aug; 18(1):806. PubMed ID: 30092761
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors.
Newton HB; Slivka MA; Volpi C; Bourekas EC; Christoforidis GA; Baujan MA; Slone W; Chakeres DW
J Neurooncol; 2003 Jan; 61(1):35-44. PubMed ID: 12587794
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic intra-arterial bio-chemotherapy for the treatment of melanoma patients with liver metastasis: a phase II clinical study].
Cui CL; Chi ZH; Yuan XQ; Lian HY; Si L; Guo J
Ai Zheng; 2008 Aug; 27(8):845-50. PubMed ID: 18710619
[TBL] [Abstract][Full Text] [Related]
16. Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study.
Lassaletta A; Scheinemann K; Zelcer SM; Hukin J; Wilson BA; Jabado N; Carret AS; Lafay-Cousin L; Larouche V; Hawkins CE; Pond GR; Poskitt K; Keene D; Johnston DL; Eisenstat DD; Krishnatry R; Mistry M; Arnoldo A; Ramaswamy V; Huang A; Bartels U; Tabori U; Bouffet E
J Clin Oncol; 2016 Oct; 34(29):3537-3543. PubMed ID: 27573663
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial chemotherapy for brain stem glioma: report of four cases.
Fujiwara T; Ogawa T; Irie K; Tsuchida T; Nagao S; Ohkawa M
Neuroradiology; 1994; 36(1):74-9. PubMed ID: 8108006
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
Finlay JL; Boyett JM; Yates AJ; Wisoff JH; Milstein JM; Geyer JR; Bertolone SJ; McGuire P; Cherlow JM; Tefft M
J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011
[TBL] [Abstract][Full Text] [Related]
19. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
Jahnke K; Kraemer DF; Knight KR; Fortin D; Bell S; Doolittle ND; Muldoon LL; Neuwelt EA
Cancer; 2008 Feb; 112(3):581-8. PubMed ID: 18072268
[TBL] [Abstract][Full Text] [Related]
20. Preirradiation ifosfamide, carboplatin, and etoposide for the treatment of anaplastic astrocytomas and glioblastoma multiforme: a phase II study.
López-Aguilar E; Sepúlveda-Vildósola AC; Rivera-Márquez H; Cerecedo-Díaz F; Hernández-Contreras I; Ramón-García G; Diegopérez-Ramírez J; Santacruz-Castillo E
Arch Med Res; 2000; 31(2):186-90. PubMed ID: 10880725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
